Overexpression of SOX2 in IR-surviving NSCLC cells has been revealed to stimulate cellular migration and anchorage-independent growth, while SOX-2 knockdown has been reported to impair their growth [324,371,372]. Here, SOX2 is linked to non-small cell lung carcinoma.